Kidney Transplant Recipient Clinical Trials

1 recruiting

Kidney Transplant Recipient Trials at a Glance

8 actively recruiting trials for kidney transplant recipient are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Boston, Aurora, and Bogotá. Lead sponsors running kidney transplant recipient studies include IRCCS Azienda Ospedaliero-Universitaria di Bologna, Massachusetts General Hospital, and Fundación Universitaria del Area Andina.

Browse kidney transplant recipient trials by phase

Treatments under study

About Kidney Transplant Recipient Clinical Trials

Looking for clinical trials for Kidney Transplant Recipient? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Kidney Transplant Recipient trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Kidney Transplant Recipient clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 2

The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients

Kidney Transplant Recipients
University Health Network, Toronto20 enrolled1 locationNCT05938712
Recruiting

Vascular Complications After Kidney Transplantation

Heart FailureKidney Transplant; ComplicationsRenovascular Hypertension+4 more
University of Aarhus60 enrolled3 locationsNCT07531966
Recruiting
Not Applicable

Diode Laser-Assisted Periodontal Therapy in Kidney Transplant Recipients

PeriodontitisKidney Transplant Recipients
Military Hospital 10380 enrolled2 locationsNCT07532694
Recruiting
Phase 3

Shingrix in Renal Transplant Recipients

Kidney FailureKidney TransplantationKidney Failure, Chronic+2 more
University of Colorado, Denver132 enrolled4 locationsNCT04128189
Recruiting
Early Phase 1

Pilot Trial of Supplemental Vitamin A and Nicotinamide

Skin CancerKidney Transplant Recipients
Rhode Island Hospital30 enrolled1 locationNCT05702398
Recruiting
Phase 4

Neurocognitive Function Changes With Extended-Release Tacrolimus Among Older Kidney Transplant Recipients

Old AgeKidney Transplant Recipients
Massachusetts General Hospital92 enrolled1 locationNCT06751992
Recruiting
Not Applicable

Velocity-Based Resistance Training in Kidney Transplant Recipients

Metabolic SyndromeCardiovascular Risk FactorsKidney Transplant Recipients
Fundación Universitaria del Area Andina12 enrolled1 locationNCT07370727
Recruiting
Not Applicable

Exercise and Diet Effects in Reducing Cardiovascular Risk in Kidney Transplant Recipients

Kidney Transplant Recipients
IRCCS Azienda Ospedaliero-Universitaria di Bologna275 enrolled1 locationNCT06806670